Scouting report · CAI
David Dean Halbert
Founded Caris in 2008; Chairman & CEO since; controls 43.9% of the stock
—thin record
Not ranked yet
Scouting sheet
as of 24 Sep 2026Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design50revenue, ebitda, fcf, strategic, time only · company lost money
Skin in the game—no holding or price on file
- Age
- 70src
- In the role
- 19 yr
- Promises scored
- 0
- Hit rate
- —
- Dodges / 100 answers
- —
- Airtime on calls
- —
Every promise, oldest firstno scored promises yet
What to weigh
Red flag 1
- 25,000,000 shares held by Halbert Family Capital, LLC are pledged as collateral for his personal debt, about a fifth of his 125.0m-share stakesrc
Watch 5
- The company is controlled by its founder. He holds 43.9% and all directors and officers together hold 50.0%. He is both Chairman and CEO, with a lead independent directorsrc
- Related-party aircraft: Caris uses a plane owned by his family office and leases its own plane to Caris Air, an operator affiliated with him. He and his family also use the company's plane personally under a time-sharing agreement signed in October 2025. Net payments to Caris Air were $2.1m in 2025src
- 2025 pay totalled $20.35m, up from $2.25m in 2024. It included $1.5m in special cash bonuses for completing the crossover round and the IPO, 360,750 RSUs that vested outright on the IPO, and $925,773 of personal securitysrc
- As an emerging growth company, Caris holds no say-on-pay vote and discloses no CD&A or CEO pay ratio. At the June 2026 meeting 17.4% of votes cast were withheld from his re-electionsrc
- The 10-Q he signed reports disclosure controls not effective at 2026-06-30, because a material weakness (too few qualified accounting staff) found in the FY2024 audit is still unremediatedsrc
Career
- 2008 – nowCaris Life Sciencessrc
Founder, Chairman & CEO
Led the April 2025 private crossover financing and the June 2025 IPO at $21 a share - 2005 – 2011Caris Diagnosticssrc
Chairman & CEO
Texas gastrointestinal-pathology company and Caris Life Sciences' former parent; sold to Miraca Life Sciences in 2011 - 1987 – 2004AdvancePCSsrc
Founder, Chairman & CEO
Prescription benefit plan administrator he founded in 1987; merged with CVS Caremark in 2004. The search summary puts the sale at $7.5bn and revenue above $15bn (WS-bio), not checked against a filing
Not located: 2004 to 2005, between the AdvancePCS merger and Caris Diagnostics, is not described in any source read
Achievements
- Founded Caris in 2008 and has been its Chairman and CEO from the start, through the June 2025 IPOsrc
- Founded AdvancePCS in 1987 and ran it as Chairman and CEO until its 2004 merger with CVS Caremarksrc
- Ran Caris Diagnostics, Caris Life Sciences' former parent, from 2005 until its 2011 sale to Miraca Life Sciencessrc
- GAAP net loss narrowed from $341.4m in FY2023 to $281.9m in FY2024 and $68.1m in FY2025src
- Beneficially owns 125.0m shares (43.9%), mostly through family partnerships and trusts he controlssrc
Education
Background
- Family His brother Jon S. Halbert, who co-founded AdvancePCS with him, has sat on the Caris board since 2014. The proxy names no other family relationship among directors and officerssrc
- Family His son was an employee from June 2011 and later Senior Vice President, Human Resources. He was not an executive officer. He left voluntarily under a transition agreement signed in November 2025, resigning on 2026-05-16, and received $435,930 in cash for 2025src
- Family He and his spouse personally guarantee the lease on the Irving, Texas head office, which runs to April 2028src
- Family Immediate family members bought 22,000 shares at the $21 IPO price through the directed share programsrc
- Giving He and his family created the Caris Foundation in 2002 and are its only funders. It is a private foundation that helps impoverished people meet basic needssrc
- Giving According to the search summary, he and his wife gave $15m toward the Halbert-Walling Research Center at Abilene Christian University, which opened in 2017src
- Other Three board members go back with him. Laura Johansen, an independent director on the compensation committee, ran his family office (Halbert & Associates) from 2004 to 2010 and was AdvancePCS general counsel. Danny Phillips, the audit chair, was AdvancePCS CFO. His brother Jon was AdvancePCS vice chairmansrc
- Other He has no change-in-control plan participation (all other senior executives have one) and no disclosed employment agreement, only an inventions-assignment agreementsrc
The promise ledger
No promise on the record yet: the research routine has not scored this company's guidance.
Sources
9- Filing Caris Life Sciences DEF 14A (accession 0002019410-26-000032) · 2026-04-23
- Filing Caris Life Sciences 8-K Item 5.07, 2026 annual meeting results (0002019410-26-000046) · 2026-06-05
- Filing Caris Life Sciences IPO prospectus, 424B4 (0001104659-25-060762) · 2025-06-20
- Filing Caris Life Sciences 10-Q for the quarter ended 2026-06-30 (0002019410-26-000055) · 2026-08-05
- Filing SEC XBRL companyconcept us-gaap/NetIncomeLoss, CIK 2019410 (FY2025 10-K, 0002019410-26-000016) · 2026-03-03
- Filing Form 3, David D. Halbert and affiliated entities (reporting CIK 1034380), at the IPO (0001104659-25-060379) · 2025-06-17
- Filing Form 4, David D. Halbert, RSU grant of 2026-03-06 (0001034380-26-000002) · 2026-03-10
- Filing Form 4, David D. Halbert, tax withholding on RSU vesting of 2026-05-15 (0001034380-26-000004) · 2026-05-18
- Web search result WebSearch: David Dean Halbert Caris Life Sciences founder AdvancePCS biography Abilene Christian (result summary drawing on the Caris bio page and Abilene Christian University posts) · 2026-09-24